Genetic Signatures Ltd. ( ($AU:GSS) ) has shared an announcement. Genetic Signatures Ltd. announced the issuance of 1,016,859 performance rights ...

Genetic Signatures Ltd. ( ($AU:GSS) ) has issued an announcement. Genetic Signatures Ltd has updated the remuneration for its CEO, Allison ...

Susan Lois Hamilton, chair of the Department of Integrated Physiology, received her Ph.D. in biophysics from the University ...

DNA isn't just a long string of genetic code, but an intricate 3D structure folded inside each cell. That means the tools ...

Scientists from Oxford's Radcliffe Department of Medicine have achieved the most detailed view yet of how DNA folds and ...

Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, announced it will share 11 new research studies highlighting advancements in oncology and ...

Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, announced it will share 11 new research ...

Molecular diagnostics firm BillionToOne raised $273.1 million in its U.S. initial public offering on Wednesday, pricing its shares above its marketed range.

Get the latest insights from OraSure Technologies' Q3 2025 earnings call—portfolio expansion, BioMedomics acquisition, growth strategy, and financial outlook.

Inclusion in the ENDO 1000 study in the UK for multiple sample types is presented as evidence of market validation for OraSure Technologies' collection kits, as described in the Q3 2025 earnings call, ...

BillionToOne, Inc (NASDAQ: BLLN) IPO will take place November, 06 on the NASDAQ exchange under the ticker BLLN. The company is offering shares at an expected price between $49.00 and $55.00 per share ...